Imbalance Towards Th1 Predominance is Associated with Acceleration of Lupus-like Autoimmune Syndrome in MRL Mice

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1996 Apr 1

PMID 8601623

Citations 73

Authors

S Takahashi

L Fossati

M Iwamoto

R Merino

R Motta

T Kobayakawa

S Izui

Affiliations

Soon will be listed here.

Abstract

To investigate the respective roles of Th1 and Th2 cells in the pathogenesis of lupus-like autoimmune disease, we have analyzed the spontaneous and antigen-induced productions of IgG1 vs IgG2a and IgG3 subclasses in relation to the mRNA expression of INF-gamma (Th1 cytokine promoting IgG2a and IgG3 production), IL-4 (Th2 cytokine promoting IgG1 production), and IL-10 (Th2 cytokine) in CD4+ T cells from lupus-prone MRL mice. For this purpose, two paired sets of MRL mice were chosen for the comparison of these parameters: (a) MRL-lpr/lpr (lpr for lymphoproliferation) and its recently described substrain with a prolonged survival, termed MRL-lpr/lpr.ll (ll for long lived) and (b) MRL male mice bearing the Yaa (Y-linked autoimmune acceleration) gene (MRL.Yaa) with an accelerated disease and their male counterparts lacking the Yaa gene. We demonstrate herein that the accelerated development of lupus-like autoimmune disease in MRL-lpr/lpr and MRL.Yaa mice, as compared with MRL-lpr/lpr.ll and MRL-+/+ mice, respectively, was correlated with an enhanced expression of IFN-gamma vs IL-4 and IL-10 mRNA in CD4+ T cells, which paralleled with an increase of spontaneous and foreign T cell-dependent antigen-induced productions of IgG2a and IgG3 vs IgG1 antibodies. These data suggest that an imbalance towards Th1 predominance may play a significant role in the acceleration of lupus-like autoimmune disease in MRL mice.

Citing Articles

A new generation of mesenchymal stromal/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment.

Hoseinzadeh A, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Tavakol Afshari J, Hosseini S Stem Cell Res Ther. 2023; 14(1):358.

PMID: 38072921 PMC: 10712058. DOI: 10.1186/s13287-023-03578-z.

Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models.

Jiwrajka N, Toothacre N, Beethem Z, Sting S, Forsyth K, Dubin A J Autoimmun. 2023; 139:103084.

PMID: 37399593 PMC: 11140471. DOI: 10.1016/j.jaut.2023.103084.

Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications.

Li J, Luo M, Li B, Lou Y, Zhu Y, Bai X Front Immunol. 2022; 13:843192.

PMID: 35359961 PMC: 8960601. DOI: 10.3389/fimmu.2022.843192.

Real-Life Cause-Effect Relations Between Urinary IL-6 Levels and Specific and Nonspecific Symptoms in a Patient With Mild SLE Disease Activity.

Schubert C, Seizer L, Chamson E, Konig P, Sepp N, Ocana-Peinado F Front Immunol. 2022; 12:718838.

PMID: 34975831 PMC: 8718908. DOI: 10.3389/fimmu.2021.718838.

Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).

Datta S Front Immunol. 2021; 12:629807.

PMID: 33936042 PMC: 8080879. DOI: 10.3389/fimmu.2021.629807.

References

Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu D . Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992; 89(5):1890-3. PMC: 48559. DOI: 10.1073/pnas.89.5.1890. View

Berney T, Fulpius T, Shibata T, Reininger L, Van Snick J, Shan H . Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass. Int Immunol. 1992; 4(1):93-9. DOI: 10.1093/intimm/4.1.93. View

Snapper C, McIntyre T, Mandler R, Pecanha L, Finkelman F, Lees A . Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med. 1992; 175(5):1367-71. PMC: 2119217. DOI: 10.1084/jem.175.5.1367. View

Lemoine R, Berney T, Shibata T, Fulpius T, Gyotoku Y, Shimada H . Induction of "wire-loop" lesions by murine monoclonal IgG3 cryoglobulins. Kidney Int. 1992; 41(1):65-72. DOI: 10.1038/ki.1992.9. View

Takahashi S, Itoh J, Nose M, Ono M, Yamamoto T, KYOGOKU M . Cloning and cDNA sequence analysis of nephritogenic monoclonal antibodies derived from an MRL/lpr lupus mouse. Mol Immunol. 1993; 30(2):177-82. DOI: 10.1016/0161-5890(93)90089-t. View

Snapper C, Mond J . Towards a comprehensive view of immunoglobulin class switching. Immunol Today. 1993; 14(1):15-7. DOI: 10.1016/0167-5699(93)90318-F. View

Fulpius T, Spertini F, Reininger L, Izui S . Immunoglobulin heavy chain constant region determines the pathogenicity and the antigen-binding activity of rheumatoid factor. Proc Natl Acad Sci U S A. 1993; 90(6):2345-9. PMC: 46083. DOI: 10.1073/pnas.90.6.2345. View

Fossati L, Takahashi S, Merino R, Iwamoto M, Aubry J, Nose M . An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome. Int Immunol. 1993; 5(5):525-32. DOI: 10.1093/intimm/5.5.525. View

Trinchieri G . Interleukin-12 and its role in the generation of TH1 cells. Immunol Today. 1993; 14(7):335-8. DOI: 10.1016/0167-5699(93)90230-I. View

10.

Merino R, Iwamoto M, Fossati L, Izui S . Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. J Immunol. 1993; 151(11):6509-16. View

11.

Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M . Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994; 179(1):305-10. PMC: 2191319. DOI: 10.1084/jem.179.1.305. View

12.

Wu J, Zhou T, Zhang J, He J, Gause W, Mountz J . Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal Fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc Natl Acad Sci U S A. 1994; 91(6):2344-8. PMC: 43367. DOI: 10.1073/pnas.91.6.2344. View

13.

Jevnikar A, Grusby M, Glimcher L . Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med. 1994; 179(4):1137-43. PMC: 2191453. DOI: 10.1084/jem.179.4.1137. View

14.

Fossati L, Iwamoto M, Merino R, Izui S . Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens. Eur J Immunol. 1995; 25(1):166-73. DOI: 10.1002/eji.1830250128. View

15.

Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J . Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med. 1995; 181(3):839-44. PMC: 2191898. DOI: 10.1084/jem.181.3.839. View

16.

Erausquin C, Merino R, Izui S, Saez F, Fernandez F, Rodriguez-Valverde V . Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes. Cell Immunol. 1995; 161(2):207-12. DOI: 10.1006/cimm.1995.1028. View

17.

Merino R, Fossati L, Iwamoto M, Takahashi S, Lemoine R, Ibnou-Zekri N . Effect of long-term anti-CD4 or anti-CD8 treatment on the development of lpr CD4- CD8- double negative T cells and of the autoimmune syndrome in MRL-lpr/lpr mice. J Autoimmun. 1995; 8(1):33-45. DOI: 10.1006/jaut.1995.0003. View

18.

Andrews B, Eisenberg R, Theofilopoulos A, Izui S, Wilson C, McCONAHEY P . Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med. 1978; 148(5):1198-215. PMC: 2185049. DOI: 10.1084/jem.148.5.1198. View

19.

Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

20.

Oi V, Herzenberg L . Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. Mol Immunol. 1979; 16(12):1005-17. DOI: 10.1016/0161-5890(79)90034-8. View